Vaginal Atrophy
📧 Sign up to get email alerts when something new happens for Vaginal Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Laser Treatment of Genito-urinary Syndrome in Women [NA]
A clinical trial investigating laser treatment for genitourinary syndrome of menopause in women has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors [Phase 2]
Phase 2 trial evaluating vaginal DHEA for vaginal atrophy and menopausal symptoms in postmenopausal breast cancer survivors on aromatase inh…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy [NA]
This update notes the completion of a clinical evaluation study of Fractional Bi-Polar Radio-Frequency therapy for symptoms of vulvovaginal …
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women [Phase 3]
Phase 3 trial evaluating hydration and acceptability of a vaginal moisturizer in menopausal women; recruitment has not yet begun.
-
FDA approval · 2024-08-02FDA Approved: ESTRADIOL VAGINAL INSERTS — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's estradiol vaginal inserts via an original application (ANDA) as a generic estrogen therapy for postmenopausa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy [Phase 3]
Phase 3 clinical trial evaluating the efficacy of a topical vaginal oxytocin gel for vulvovaginal atrophy in postmenopausal women; the study…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy [Phase 3]
Phase 3 study evaluating equivalence of estradiol vaginal cream to the reference standard for vulvar and vaginal atrophy has completed, with…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy [Phase 4]
Phase 4 clinical trial completed and results posted evaluating the vaginal microbiome of postmenopausal women and their response to estrogen…
-
FDA approval · 2024-02-15FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) from Wyeth/Pfizer, updating labeling for the product.
-
FDA approval · 2024-02-15FDA Approved: ESTRING — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for ESTRING (estradiol) from Pfizer Laboratories, updating labeling for the product.
-
FDA approval · 2024-01-29FDA Approved: ESTRADIOL VAGINAL — Supplemental Application (Encube Ethicals, Inc.)
The FDA approved a supplemental application for Estradiol Vaginal (ESTRADIOL) from Encube Ethicals, Inc., updating the labeling/approval sta…
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman [Phase 2, Phase 3]
A Phase 2/3 clinical trial assessing the effects of vaginal oxytocin gel on vaginal cytology in postmenopausal women with vaginal atrophy ha…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Radiofrequency and Hybrid Fractional Laser for Vaginal Rejuvenation [NA]
Clinical trial on radiofrequency and hybrid fractional laser for vaginal rejuvenation completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness [Phase 4]
Phase 4 trial update on WO 2707 moist cream (Cremolum) for vaginal dryness in postmenopausal women with vaginal atrophy; study completed.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function [Phase 4]
Phase 4 clinical trial update on vaginal estrogen for vaginal atrophy assessing postpartum atrophy, perineal pain, and sexual function.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy. [Phase 3]
Phase 3 trial evaluating low concentration estriol (0.005%) for efficacy and safety in postmenopausal vaginal atrophy has completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women [Phase 2]
A Phase 2 clinical trial investigating dose relationship of vaginally administered oxytocin in postmenopausal women with vaginal atrophy has…
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy [Phase 2]
Phase 2 trial completed evaluating three ultra-low-dose estriol vaginal gels for vaginal dryness in postmenopausal women with vulvovaginal a…
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting [Phase 2]
Phase 2 trial assessing safety of 0.005% estriol vaginal gel in postmenopausal women with early-stage, hormone receptor–positive breast canc…
-
FDA approval · 2019-04-09FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)
FDA has approved a supplemental application for Vagifem (estradiol) filed by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Efficacy and Safety Of Spil's Estradiol Vaginal Tablet [Phase 3]
Phase 3 trial update for Spil's estradiol vaginal tablet assessing efficacy and safety; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: The Vaginal Health Trial [Phase 3]
Phase 3 Vaginal Health Trial sponsored by Fred Hutchinson Cancer Center completed with results posted in July 2018, evaluating treatment for…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes [NA]
A completed clinical trial evaluated the effects of a moisturizing cream on vaginal and vulvar mucous membranes for vaginal dryness and vagi…
-
CLINICAL_TRIALS research · 2018-06-14Clinical Trial Update: Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments [NA]
Clinical trial update for the CO2RE Laser Device in treating vaginal atrophy; current status is unknown.
-
CLINICAL_TRIALS research · 2018-05-09Clinical Trial Update: Evaluation of Efficacy and Safety of Votiva for Vaginal Rejuvenation [NA]
Clinical trial update evaluating the efficacy and safety of the Votiva device for vaginal rejuvenation, including conditions such as vaginal…